Back to mobile site

More on CMPS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+75.0% Growth)
- Ratings (9.0 Score)

Upcoming Events

- Earnings (10/29/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

COMPASS Pathways plc (NQ:CMPS)
Delayed: 15.08 +1.28 (9.28%)
Prev. Close $13.80  
Open$14.06 
52 Wk High$ 
52 Wk Low$ 
Day High$15.41 
Day Low$14.00 
P/E N/A  
EPS$ 
Volume2,395,057 

Friends, Peers and Foes (?): DFTX, ATAI, HELP, GHRS, SPRO (more...)

Sep 16, 2026 06:30 AM Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026
Sep 16, 2026 05:31 AM Oppenheimer sees positive outlook for psychedelics after FDA hearing
Sep 15, 2026 06:30 AM Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 2026
Sep 11, 2026 04:10 PM Strata Mental Health gets Compass Pathways grant for COMP360 training
Sep 11, 2026 04:10 PM Strata Mental Health Solutions Awarded U.S. Healthcare Provider Training Grant from Compass Pathways to Develop Provider Training for COMP360
Sep 10, 2026 08:01 AM Fluence to develop psilocybin provider training for Compass Pathways
Sep 10, 2026 08:00 AM Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training
Sep 10, 2026 06:35 AM Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval COMP360 Provider Training
Sep 10, 2026 06:30 AM Compass Pathways to Participate in Investor Conferences the Week of September 14th
Sep 9, 2026 03:20 PM Oppenheimer Reiterates Outperform Rating on Compass Pathways (CMPS)
View All Articles

Entities mentioned with CMPS

View All Entities